Status:
COMPLETED
The Utility of Breath Biopsy as a Screening Tool for HCC
Lead Sponsor:
University of Aberdeen
Conditions:
HCC
Cirrhosis, Liver
Eligibility:
All Genders
18-80 years
Brief Summary
The aim of this pilot study is to examine whether there is a discriminating ability of the breath sample analysis to capture biomarkers specific to the HCC in the breath of affected individuals. If po...
Detailed Description
20 Participants will be included in the study. Ten Cirrhotic patients with HCC and 10 Cirrhotic patients without HCC. The first group is patients with HCC secondary to cirrhosis. The second group wil...
Eligibility Criteria
Inclusion
- Cirrhotic patients with HC.
- Cirrhotic patients without HCC
Exclusion
- Patients with more than one primary cancer (HCC in addition to other cancer)
- Patients who are not aware of the diagnosis
- Patients in whom the diagnosis of HCC is not clear and only suspected
- Patients with severe chronic obstructive pulmonary disease (COPD) or severe asthma.
Key Trial Info
Start Date :
June 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 16 2022
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04326491
Start Date
June 20 2021
End Date
May 16 2022
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ashis Mukhopadhya
Aberdeen, United Kingdom